Food News and Research

RSS

COIN hosts nanobiotechnology event on nanomedicines and the regulatory path

The Center of Innovation for Nanobiotechnology (COIN) today announced the upcoming NanoBio Executive Roundtable event to be hosted at RTP Foundation in Durham, NC on May 17, 2011. This Roundtable will tackle regulatory issues surrounding nanomedicine commercialization. The “Nanomedicines and the Regulatory Path” Roundtable will kick off with a presentation from Katherine Tyner, Ph.D., a Chemist in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).

5 May 2011

$Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study$

Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study

According to a new study, nearly 78% of all Swedish women aged 55 years and older who sustained a thigh bone or femur fracture in 2008 had taken bisphosphonates for their osteoporosis. However the authors of the study published in the May 5 issue of the New England Journal of Medicine (NEJM) write that the absolute risk for such breaks is small enough to justify prescribing the drugs.

5 May 2011

Hendra virus alert among horse owners

Hendra virus is a bat-borne virus that has killed four of the seven humans who have been infected and caused the deaths more than 40 horses since it was discovered in 1994. Humans contract the disease from horses but there has been neither human-to-human transmission of the disease nor direct transmission from bats to humans report experts. The majority of outbreaks have occurred during June and October, however last year a horse in Tewantin contracted the virus in May.

5 May 2011

Acorda reports $0.7 million GAAP net loss for first quarter 2011

Acorda Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2011.

5 May 2011

Boston Business Journal honors Tufts Health Plan for Worksite Wellness program

Tufts Health Plan recently received the prestigious honor of being recognized for its Worksite Wellness initiatives by the Boston Business Journal. As a finalist in the Boston Business Journal's listing of "HEALTHIEST EMPLOYERS," the non profit company was recognized as an organization that is deeply committed to improving the health of its employees and its workplace.

5 May 2011

The Miami Project, InVivo Therapeutics collaborate to develop novel spinal cord injury treatments

InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, and The University of Miami Miller School of Medicine's Miami Project to Cure Paralysis, the world's most comprehensive spinal cord injury research center, today announced a strategic research collaboration for the development of novel SCI treatments.

5 May 2011

FDA releases final guidance to firms that market OTC drug products

The U.S. Food and Drug Administration today released its final guidance to firms that manufacture, market, or distribute over-the-counter liquid drug products packaged with cups, droppers, syringes, and spoons to measure and dispense the doses of medication.

5 May 2011

Columbia Laboratories net revenues increase 74% to $12.5 million

Columbia Laboratories, Inc. today reported financial results for the three-month period ended March 31, 2011.

5 May 2011

U.N. report forecasts global population increases through 2100

The world's population "is expected to grow from nearly 6.9 billion currently to 9.3 billion by 2050 and 10.1 billion by 2100," the U.N. said in a report on Tuesday, the Associated Press reports, noting that the U.N. uses the projections "to devise and fund programs for problems ranging from climate change to maternal mortality".

5 May 2011

UCF to develop safe, inexpensive and effective polio vaccine

An innovative way of making vaccines at the University of Central Florida has attracted the support of the Bill & Melinda Gates Foundation for its potential to make vaccines lessexpensive, more effective and needle free.

5 May 2011

EraGen workshop to address two topics on real-time PCR-based viral monitoring tests

EraGen Biosciences Inc. today announced that it will host a corporate workshop at the upcoming Clinical Virology Symposium, which is being held May 8-11 in Daytona Beach, Fla. The workshop will take place at 1 p.m. on Tuesday, May 10, at the Ocean Center in Daytona Beach.

5 May 2011

Staying up late and sleeping in can increase risk for gaining weight

Staying up late every night and sleeping in is a habit that could put you at risk for gaining weight. People who go to bed late and sleep late eat more calories in the evening, more fast food, fewer fruits and vegetables and weigh more than people who go to sleep earlier and wake up earlier, according to a new Northwestern Medicine study.

5 May 2011

Group of foundations launches food, agriculture policy research initiative

A group of foundations on Tuesday in Washington launched AGree, a food and agriculture research initiative, Bloomberg reports.

5 May 2011

Study: XMRV retrovirus is not present in chronic fatigue syndrome patients

New findings from University of Utah School of Medicine researchers show that the retrovirus called XMRV is not present in the blood of patients who have chronic fatigue syndrome.

5 May 2011

Penn State receives USDA grant for childhood obesity prevention training program

Sustainable, comprehensive and problem-based training to prevent child obesity will now be possible thanks to a $4.5 million, five-year grant from the U.S. Department of Agriculture.

5 May 2011

Acetyl resveratrol could protect against radiation sickness

In the midst of ongoing concerns about radiation exposure from the Fukushima nuclear power plant in Japan, scientists are reporting that a substance similar to resveratrol - an antioxidant found in red wine, grapes and nuts - could protect against radiation sickness. The report appears in ACS Medicinal Chemistry Letters.

5 May 2011

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI Corporation announced today that it has received approval to begin enrollment of patients in its Phase III clinical trial of Multikine® from the Polish Minister of Health. This approval marks a very important milestone, namely that all nine countries in the study have now given official government approval. Five of about 48 clinical centers for this global trial will be located in Poland.

5 May 2011

Submandibular gland transfer can help prevent dry mouth in cancer patients

For patients suffering from cancer in the mouth or throat, a recent study shows that a treatment called submandibular gland transfer will assist in preventing a radiation-induced condition called xerostomia.

5 May 2011

Selexys begins patient enrollment in SelG1 Phase I study for sickle cell disease

Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.

5 May 2011

Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan

Durata Therapeutics today announced the Company has received positive Scientific Advice from the European Medicines Agency on the pivotal clinical development plan for dalbavancin, Durata's long-acting, intravenous lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections.

4 May 2011